Biosenic (STU:BT1) ROE % Adjusted to Book Value : Negative Equity% (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Biosenic ROE % Adjusted to Book Value?

Biosenic's ROE % for the quarter that ended in Jun. 2024 was Negative Equity. Biosenic's PB Ratio for the quarter that ended in Jun. 2024 was N/A. Biosenic's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was Negative Equity.

Biosenic ROE % Adjusted to Book Value Historical Data

The historical data trend for Biosenic's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosenic ROE % Adjusted to Book Value Chart

Biosenic Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-17.21

-35.76

-153.83

Biosenic Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	Negative Equity

Competitive Comparison of Biosenic's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Biosenic's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosenic's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosenic's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Biosenic's ROE % Adjusted to Book Value falls into.

Biosenic ROE % Adjusted to Book Value Calculation

Biosenic's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Biosenic's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	Negative Equity	/	N/A
	=	Negative Equity

Biosenic ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Biosenic's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosenic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (STU:BT1) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

0R55:UK BIOS:Belgium

Address

Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435

Website

https://www.biosenic.com

Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.

Biosenic Headlines

No Headlines